Search Results - Tolmachev V. M. Vladimir Maksimilianovich

Refine Results
  1. 1
    Affibody Molecules as Targeting Vectors for PET Imaging

    Affibody Molecules as Targeting Vectors for PET Imaging by Tolmachev V. M. Vladimir Maksimilianovich

    Published 2020
    Get full text
    Electronic Book Chapter
  2. 2
    Therapy of HER2-expressing human xenografts in mice using 177Lu-labelled scaffold protein ABY-027: compatrison with therapy using antobody trastuzumab

    Therapy of HER2-expressing human xenografts in mice using 177Lu-labelled scaffold protein ABY-027: compatrison with therapy using antobody trastuzumab by Liu Y.

    Published 2022
    Other Authors: Get full text
    Electronic Book Chapter
  3. 3
    66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26

    66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26

    Published 2021
    Other Authors: Get full text
    Electronic Book Chapter
  4. 4
    Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99m

    Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium...

    Published 2025
    Other Authors: Get full text
    Electronic Book Chapter
  5. 5
    Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer

    Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer

    Published 2021
    Other Authors: Get full text
    Electronic Book Chapter
  6. 6
    Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model

    Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  7. 7
    Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

    Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  8. 8
    Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

    Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  9. 9
    Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

    Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  10. 10
    Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

    Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  11. 11
    Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

    Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

    Published 2023
    Other Authors: Get full text
    Electronic Book Chapter
  12. 12
    Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

    Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  13. 13
    HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

    HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  14. 14
    Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model

    Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  15. 15
    Efficient Synthesis of ω‐[18F]Fluoroaliphatic Carboxylic Esters and Acids for Positron Emission Tomography

    Efficient Synthesis of ω‐[18F]Fluoroaliphatic Carboxylic Esters and Acids for Positron Emission Tomography

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  16. 16
    Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer

    Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer

    Published 2020
    Other Authors: Get full text
    Electronic Book Chapter
  17. 17
    Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer

    Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer

    Published 2023
    Other Authors: Get full text
    Electronic Book Chapter
  18. 18
    Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

    Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

    Published 2023
    Other Authors: Get full text
    Get full text
    Electronic Book Chapter
  19. 19
    Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

    Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

    Published 2021
    Other Authors: Get full text
    Electronic Book Chapter
  20. 20
    Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3

    Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3

    Published 2023
    Other Authors: Get full text
    Electronic Book Chapter

Search Tools: